Latvia vs Malaysia: Death rate from diabetes
Latvia
13.38 deaths per 100,000 people
in 2023
Malaysia
13.01 deaths per 100,000 people
in 2020
Latvia rank
78th
Malaysia rank
79th
Death rate from diabetes over time
- Latvia
- Malaysia
How they compare
Latvia currently reports 13.38 deaths per 100,000 people against 13.01 deaths per 100,000 people in Malaysia, a difference of 0.37 deaths per 100,000 people.
The two have swapped places 3 times across 21 shared years of data; in 2000 it was Malaysia ahead.
Latvia ranks 78th and Malaysia ranks 79th of 111 countries.
Across the 3 decades both report, Latvia averaged higher in 2 and Malaysia in 1.
Head to head by decade
| Decade | Latvia | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.43 deaths per 100,000 people | 11.26 deaths per 100,000 people | 1.83 deaths per 100,000 people | Malaysia |
| 2010s | 13.3 deaths per 100,000 people | 9.07 deaths per 100,000 people | 4.23 deaths per 100,000 people | Latvia |
| 2020s | 16.17 deaths per 100,000 people | 13.01 deaths per 100,000 people | 3.16 deaths per 100,000 people | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from diabetes, Latvia or Malaysia?
- Latvia, at 13.38 deaths per 100,000 people against 13.01 deaths per 100,000 people in Malaysia as of 2023.
- What is the difference in death rate from diabetes between Latvia and Malaysia?
- 0.37 deaths per 100,000 people, with Latvia ahead.
- How many years of comparable data are there for Latvia and Malaysia?
- 21 years are reported by both, from 2000 to 2020.
- How do Latvia and Malaysia rank globally for death rate from diabetes?
- Latvia ranks 78th and Malaysia ranks 79th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Death rate from diabetes. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from diabetes mellitus, blood and endocrine disorders in both sexes in those aged all ages per 100,000 people.